Corvex Management’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$207M Buy
3,228,149
+169,520
+6% +$15.5M 8.24% 4
2025
Q4
$398M Hold
3,058,629
12.16% 3
2025
Q3
$330M Hold
3,058,629
10.93% 3
2025
Q2
$282M Buy
3,058,629
+584,848
+24% +$45.9M 11.95% 3
2025
Q1
$219M Hold
2,473,781
8.29% 4
2024
Q4
$190M Hold
2,473,781
5.24% 7
2024
Q3
$105M Hold
2,473,781
4.08% 8
2024
Q2
$64.7M Hold
2,473,781
2.99% 9
2024
Q1
$22.6M Hold
2,473,781
1.05% 23
2023
Q4
$6.8M Sell
2,473,781
-833,742
-25% -$1.94M 0.36% 22
2023
Q3
$12M Hold
3,307,523
0.65% 24
2023
Q2
$19.7M Buy
3,307,523
+676,871
+26% +$5.36M 0.97% 23
2023
Q1
$31.7M Buy
2,630,652
+2,353,436
+849% +$31.4M 1.56% 15
2022
Q4
$2.41M Sell
277,216
-205,739
-43% -$4.53M 0.13% 22
2022
Q3
$14M Hold
482,955
0.82% 23
2022
Q2
$20.1M Buy
482,955
+346,591
+254% +$23.5M 1.28% 20
2022
Q1
$13.8M Hold
136,364
0.87% 20
2021
Q4
$20.1M Hold
136,364
0.79% 23
2021
Q3
$34.2M Buy
+136,364
New +$46.8M 1.06% 26

Other funds holding WGS

Corvex Management's WGS Position: Q1 2026 in Review

Corvex Management increased its GeneDx Holdings (WGS) stake by 5.5% in Q1 2026, buying an estimated $15.5M and bringing the position to 3,228,149 shares worth $207M. The position accounts for 8.24% of the portfolio, ranked #4.

Corvex Management first reported a position in WGS in Q3 2021 and has held it in 19 quarters since. The position peaked at $398M in Q4 2025. 240 funds tracked by Wall St. Rank hold WGS as of Q1 2026.

  • Corvex Management held 3,228,149 shares of GeneDx Holdings worth $207M as of Q1 2026.
  • Corvex Management bought 169,520 GeneDx Holdings shares in Q1 2026, an estimated $15.5M.
  • GeneDx Holdings made up 8.24% of Corvex Management's portfolio in Q1 2026, its #4 holding.
  • Corvex Management first reported a position in GeneDx Holdings in Q3 2021 and has held it in 19 quarters since.
  • Corvex Management's GeneDx Holdings position peaked at $398M in Q4 2025.
  • 240 funds tracked by Wall St. Rank held GeneDx Holdings as of Q1 2026.

Based on Corvex Management's 13F filing for Q1 2026, filed 15 May 2026.